An increase in tumor‐infiltrating lymphocytes was noted in a study of ovarian cancer in syngeneic mice [21, 41], while inhibited CD8+ T cell infiltration was seen in triple‐negative breast cancer patients with low ARID1A expression [42]. Here, ARID1A is linked to neoplasm.